DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Yasons Chemex Care Limited — Board Meeting Intimation

NSE 45 min ago·22 Oct 2026, 5:46 am

Yasons Chemex Care

Yasons Chemex Care Limited has announced that its board will meet on October 31, 2026, to review and approve the company's unaudited financial results for the half-year ending September 2026. This is a standard corporate procedure where the board evaluates the company's performance over the first six months of the fiscal year before the figures are made public.

For investors, this announcement is a key update as it signals that the company is preparing to disclose its operational and financial health. The release of these results will provide clarity on revenue growth, profit margins, and overall business performance during the interim period.

Investors should watch for the actual release of the financial statements, which will detail the company's quarterly performance and future outlook. Market participants will closely analyze these figures to gauge the company's current trajectory and strategic progress.